Both IRF3 and especially IRF7 play a key role to orchestrate an effective cerebral inflammatory response in a mouse model of herpes simplex virus encephalitis

[1]  G. Boivin,et al.  Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone. , 2015, Antiviral research.

[2]  T. Ørntoft,et al.  Functional IRF3 deficiency in a patient with herpes simplex encephalitis , 2015, The Journal of experimental medicine.

[3]  G. Boivin,et al.  Innate immune response during herpes simplex virus encephalitis and development of immunomodulatory strategies , 2015, Reviews in medical virology.

[4]  S. Rivest,et al.  The combination of valacyclovir with an anti-TNF alpha antibody increases survival rate compared to antiviral therapy alone in a murine model of herpes simplex virus encephalitis. , 2013, Antiviral research.

[5]  Christopher D. Conrady,et al.  HSV-1 targets lymphatic vessels in the eye and draining lymph node of mice leading to edema in the absence of a functional type I interferon response. , 2013, The American journal of pathology.

[6]  D. Leib,et al.  Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging. , 2013, Virology.

[7]  P. Kennedy,et al.  Recent issues in herpes simplex encephalitis , 2013, Journal of NeuroVirology.

[8]  G. Boivin,et al.  Both TRIF and IPS-1 Adaptor Proteins Contribute to the Cerebral Innate Immune Response against Herpes Simplex Virus 1 Infection , 2013, Journal of Virology.

[9]  T. Michiels,et al.  Antiviral Type I and Type III Interferon Responses in the Central Nervous System , 2013, Viruses.

[10]  J. Casanova,et al.  TLR3 immunity to infection in mice and humans. , 2013, Current opinion in immunology.

[11]  W. Tyor,et al.  Interferon-α (IFNα) neurotoxicity. , 2012, Cytokine & growth factor reviews.

[12]  H. Agut,et al.  Herpes simplex encephalitis : from virus to therapy. , 2011, Infectious disorders drug targets.

[13]  A. Bowie,et al.  Recognition of herpesviruses by the innate immune system , 2011, Nature Reviews Immunology.

[14]  A. Bowie,et al.  Activation of host pattern recognition receptors by viruses. , 2010, Current opinion in microbiology.

[15]  Vineet D. Menachery,et al.  Interferon Regulatory Factor 3-Dependent Pathways Are Critical for Control of Herpes Simplex Virus Type 1 Central Nervous System Infection , 2010, Journal of Virology.

[16]  Christopher D. Conrady,et al.  Herpes simplex type I (HSV-1) infection of the nervous system: Is an immune response a good thing? , 2010, Journal of Neuroimmunology.

[17]  Vineet D. Menachery,et al.  Control of Herpes Simplex Virus Replication Is Mediated through an Interferon Regulatory Factor 3-Dependent Pathway , 2009, Journal of Virology.

[18]  K. Mossman,et al.  Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production. , 2009, Molecular immunology.

[19]  J. Tyszka,et al.  The Immune Response to Herpes Simplex Virus Type 1 Infection in Susceptible Mice Is a Major Cause of Central Nervous System Pathology Resulting in Fatal Encephalitis , 2008, Journal of Virology.

[20]  S. Rivest,et al.  Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. , 2007, The Journal of infectious diseases.

[21]  S. Rivest,et al.  Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis. , 2007, The Journal of infectious diseases.

[22]  Hideo Negishi,et al.  IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.

[23]  R. Bronson,et al.  Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Tyler.  Update on herpes simplex encephalitis. , 2004, Reviews in neurological diseases.

[25]  G. Luker,et al.  Bioluminescence Imaging Reveals Systemic Dissemination of Herpes Simplex Virus Type 1 in the Absence of Interferon Receptors , 2003, Journal of Virology.

[26]  P. Pitha,et al.  On the role of IRF in host defense. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[27]  J. Hiscott,et al.  Multiple Regulatory Domains Control IRF-7 Activity in Response to Virus Infection* , 2000, The Journal of Biological Chemistry.

[28]  Robert H. Silverman,et al.  Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH2-Terminal Kinase by Double-Stranded RNA and Encephalomyocarditis Virus: Involvement of RNase L, Protein Kinase R, and Alternative Pathways , 2000, Molecular and Cellular Biology.

[29]  M. Karin,et al.  The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. , 2000, Seminars in immunology.

[30]  T. Taniguchi,et al.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. , 2000, Immunity.

[31]  M. Karin,et al.  JNK2 and IKKbeta are required for activating the innate response to viral infection. , 1999, Immunity.

[32]  H. Virgin,et al.  Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo , 1999, The Journal of experimental medicine.

[33]  T. Taniguchi,et al.  Positive feedback regulation of type I IFN genes by the IFN‐inducible transcription factor IRF‐7 , 1998, FEBS letters.

[34]  T. Taniguchi,et al.  Critical role of a common transcription factor, IRF‐1, in the regulation of IFN‐beta and IFN‐inducible genes. , 1992, The EMBO journal.

[35]  T. Taniguchi,et al.  Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. , 1989, Nature.